Hanson & Doremus Investment Management Merck & Co., Inc. Transaction History

Hanson & Doremus Investment Management

  • $748 Million
  • Q2 2025

A detailed history of Hanson & Doremus Investment Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Hanson & Doremus Investment Management holds 85,739 shares of MRK stock, worth $7.08 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
85,739
Previous 61,511 39.39%
Holding current value
$7.08 Million
Previous $5.52 Million 22.93%
% of portfolio
0.91%
Previous 0.81%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 17, 2025
BUY
$73.47 - $87.12 $1.78 Million - $2.11 Million
24,228 Added 39.39%
85,739 $6.79 Million
Q1 2025

Apr 17, 2025
BUY
$83.01 - $101.02 $644,157 - $783,915
7,760 Added 14.44%
61,511 $5.52 Million
Q4 2024

Jan 23, 2025
BUY
$96.31 - $114.76 $133,100 - $158,598
1,382 Added 2.64%
53,751 $5.35 Million
Q3 2024

Oct 17, 2024
SELL
$111.15 - $128.97 $185,175 - $214,864
-1,666 Reduced 3.08%
52,369 $5.95 Million
Q2 2024

Aug 08, 2024
BUY
$123.8 - $132.96 $45,558 - $48,929
368 Added 0.69%
54,035 $6.69 Million
Q1 2024

Apr 22, 2024
BUY
$113.24 - $131.95 $26,724 - $31,140
236 Added 0.44%
53,667 $7.08 Million
Q4 2023

Jan 25, 2024
BUY
$100.18 - $109.02 $193,046 - $210,081
1,927 Added 3.74%
53,431 $5.83 Million
Q3 2023

Oct 24, 2023
SELL
$102.95 - $114.33 $3,706 - $4,115
-36 Reduced 0.07%
51,504 $5.3 Million
Q2 2023

Jul 18, 2023
BUY
$108.61 - $118.38 $138,260 - $150,697
1,273 Added 2.53%
51,540 $5.95 Million
Q1 2023

Apr 18, 2023
SELL
$102.94 - $114.86 $798,505 - $890,969
-7,757 Reduced 13.37%
50,267 $5.35 Million
Q4 2022

Jan 18, 2023
BUY
$87.44 - $112.11 $722,254 - $926,028
8,260 Added 16.6%
58,024 $6.44 Million
Q3 2022

Oct 20, 2022
BUY
$84.53 - $94.96 $202,618 - $227,619
2,397 Added 5.06%
49,764 $4.29 Million
Q2 2022

Jul 19, 2022
BUY
$83.49 - $94.64 $122,980 - $139,404
1,473 Added 3.21%
47,367 $4.32 Million
Q1 2022

Apr 22, 2022
BUY
$73.51 - $82.4 $77,994 - $87,426
1,061 Added 2.37%
45,894 $3.77 Million
Q4 2021

Jan 20, 2022
BUY
$72.28 - $90.54 $170,436 - $213,493
2,358 Added 5.55%
44,833 $3.44 Million
Q3 2021

Oct 21, 2021
BUY
$71.68 - $78.83 $1.18 Million - $1.29 Million
16,415 Added 62.99%
42,475 $3.19 Million
Q2 2021

Jul 22, 2021
SELL
$70.31 - $77.77 $805,611 - $891,088
-11,458 Reduced 30.54%
26,060 $2.16 Million
Q1 2021

May 03, 2021
BUY
$68.86 - $81.11 $206,855 - $243,654
3,004 Added 8.7%
37,518 $2.89 Million
Q4 2020

Feb 01, 2021
BUY
$71.77 - $79.65 $606,743 - $673,361
8,454 Added 32.44%
34,514 $2.82 Million
Q3 2020

Oct 19, 2020
BUY
$73.18 - $82.95 $34,614 - $39,235
473 Added 1.85%
26,060 $2.16 Million
Q2 2020

Jul 17, 2020
SELL
$70.42 - $80.13 $602,583 - $685,672
-8,557 Reduced 25.06%
25,587 $1.98 Million
Q1 2020

Apr 24, 2020
BUY
$63.36 - $87.82 $431,544 - $598,142
6,811 Added 24.92%
34,144 $2.51 Million
Q4 2019

Jan 16, 2020
BUY
$77.58 - $87.54 $69,899 - $78,873
901 Added 3.41%
27,333 $2.49 Million
Q3 2019

Oct 18, 2019
SELL
$76.08 - $82.93 $40,702 - $44,367
-535 Reduced 1.98%
26,432 $2.23 Million
Q2 2019

Jul 18, 2019
SELL
$69.84 - $81.59 $121,242 - $141,640
-1,736 Reduced 6.05%
26,967 $2.26 Million
Q1 2019

Apr 23, 2019
SELL
$69.58 - $79.36 $2,087 - $2,380
-30 Reduced 0.1%
28,703 $0
Q4 2018

Jan 31, 2019
SELL
$65.24 - $75.71 $69,611 - $80,782
-1,067 Reduced 3.58%
28,733 $2.2 Million
Q3 2018

Oct 24, 2018
BUY
$57.69 - $67.84 $54,055 - $63,566
937 Added 3.25%
29,800 $0
Q2 2018

Aug 08, 2018
SELL
$50.83 - $59.72 $334,512 - $393,017
-6,581 Reduced 18.57%
28,863 $1.75 Million
Q1 2018

May 10, 2018
BUY
$50.96 - $59.23 $350,400 - $407,265
6,876 Added 24.07%
35,444 $1.93 Million
Q4 2017

Jan 25, 2018
BUY
$51.62 - $61.64 $7,639 - $9,122
148 Added 0.52%
28,568 $1.61 Million
Q3 2017

Oct 26, 2017
BUY
$58.67 - $63.13 $1.67 Million - $1.79 Million
28,420
28,420 $0

Others Institutions Holding MRK

# of Institutions
3,886
Shares Held
1.93B
Call Options Held
25.6M
Put Options Held
24M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $209B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Hanson & Doremus Investment Management Portfolio

Follow Hanson & Doremus Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanson & Doremus Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hanson & Doremus Investment Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email